Back to results
Available

TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease

NCT03539380

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Contact

Sotereos Gates, PhD

+44 (0) 7771 570707s.gates@taurx.com
View on ClinicalTrials.gov
TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease — TrialFind